Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Warts × Exercise × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Motor Activity 98 Breast Neoplasms 59 Neoplasms 41 Prostatic Neoplasms 17 Obesity 13 Fatigue 12 Colorectal Neoplasms 10 Lung Neoplasms 9 Polycystic Ovary Syndrome 8 Colonic Neoplasms 8 Head and Neck Neoplasms 7 Ovarian Neoplasms 6 Weight Loss 5 Rectal Neoplasms 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Multiple Myeloma 4 Cognitive Dysfunction 4 Brain Neoplasms 4 Overweight 3 Lymphoma, Follicular 3 Lymphedema 3 Leukemia, Myeloid, Acute 3 Insulin Resistance 3 Inflammation 3 Carcinoma, Non-Small-Cell Lung 3 Breast Cancer Lymphedema 3 Breast Cancer Female 3 Urinary Bladder Neoplasms 2 Sleep Initiation and Maintenance Disorders 2 Sarcopenia 2

Interventions

Cryotherapy 7 resiquimod 5 Cholecalciferol 3 Cantharidin 3 PRA1 protein, Candida albicans 2 N-phenylacetoaminomethylene-DL-p-nitrophenylalanine 2 Measles-Mumps-Rubella Vaccine 2 2-Propanol 2 plerixafor 1 methyl 5-aminolevulinate 1 green tea extract polyphenone E 1 ammonium trichloro(dioxoethylene-O,O'-)tellurate 1 VP-102 1 Tuberculin 1 Trichloroacetic Acid 1 Sugars 1 Photochemotherapy 1 Nitric Oxide 1 Mass Screening 1 Maltose 1 Lasers 1 Interferon-alpha 1 Imiquimod 1 Human Papillomavirus Recombinant Vaccine nonavalent 1 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1 Granulocyte Colony-Stimulating Factor 1 Gels 1 Filgrastim 1 Exercise 1 Ethanol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03691831 2020-10-27

A Study of A-101 Topical Solution for the Treatment of Common Warts

Aclaris Therapeutics, Inc.

Phase 3 Completed

502 enrolled 22 charts

Warts

Data powered by HemOnc (CC BY 4.0) Colophon ⚡